Koers Epsilon Healthcare Limited Other OTC
Aandelen
HDRPF
AU0000137598
Farmaceutische producten
Omzet 2021 | 5,5 mln. 3,64 mln. 3,4 mln. | Omzet 2022 | 7,11 mln. 4,7 mln. 4,39 mln. | Marktkapitalisatie | 7,51 mln. 4,97 mln. 4,64 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -9 mln. -5,95 mln. -5,56 mln. | Nettowinst (verlies) 2022 | -13 mln. -8,6 mln. -8,03 mln. | EV/omzet 2021 | 3,26 x |
Nettoschuld 2021 | 2,1 mln. 1,39 mln. 1,3 mln. | Nettoschuld 2022 | 2,34 mln. 1,55 mln. 1,44 mln. | EV/omzet 2022 | 1,38 x |
K/w-verhouding 2021 |
-1,48
x | K/w-verhouding 2022 |
-0,38
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 60,39% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Sanghera
CEO | Chief Executive Officer | - | 21/11 |
Lin Li
AUD | Comptroller/Controller/Auditor | - | - |
Marcelo Mora
SEC | Corporate Secretary | 60 | 23-12-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Alan Beasley
CHM | Chairman | - | 29-08-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,96% | 630 mld. | |
-7,15% | 350 mld. | |
+18,77% | 328 mld. | |
+8,79% | 298 mld. | |
+18,02% | 246 mld. | |
+1,27% | 225 mld. | |
+11,95% | 218 mld. | |
+3,68% | 160 mld. | |
-4,38% | 156 mld. |